Evidence map›Paper›PMID 36702144›Full record

ReviewThe lancet. Gastroenterology & hepatology2023

Understanding and managing patients with overlapping disorders of gut-brain interaction.

Lukas Michaja Balsiger, Florencia Carbone, Karlien Raymenants, Emidio Scarpellini, Jan Tack

Abstract readReview
In one paragraph

Review in The lancet. Gastroenterology & hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Comment on "Overlap of 'disorders of gut-brain interaction' and their impact on quality of life and somatization in a tertiary care center".Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Overlapping disorders of gut-brain interaction -More may not be so merry!Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2025
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lukas Michaja BalsigerTranslational Research Center for Gastrointestinal Diseases, Department of Chronic Diseases and Metabolism.
Florencia CarboneDepartment of Gastroenterology, Leuven University Hospitals Belgium.
Karlien RaymenantsTranslational Research Center for Gastrointestinal Diseases, Department of Chronic Diseases and Metabolism.
Emidio ScarpelliniDepartment of Gastroenterology, Leuven University Hospitals Belgium.
Jan TackTranslational Research Center for Gastrointestinal Diseases, Department of Chronic Diseases and Metabolism; Department of Gastroenterology, Leuven University Hospitals Belgium; Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Rome Foundation, Raleigh, NC, USA. Electronic address: jan.tack@kuleuven.be.

Funding

Swiss National Science Foundation 206612
6 · The paper itself

Abstract

Disorders of gut-brain interaction (DGBI) are frequently encountered in clinical practice, and recommendations for diagnosis and management are well established. In a large subset of patients, more than one DGBI diagnosis is present. This group of patients with more than one DGBI diagnosis have higher symptom severity and impact than patients with only one DGBI diagnosis, and the management approach is not well established for those with overlapping diagnoses. This Review aims to guide clinicians to understand, recognise, and manage overlapping DGBI by identifying causes and pitfalls of overlap conditions, and presenting potential practical approaches to diagnosis, treatment, and follow-up. Several clinical factors can contribute to finding overlapping DGBI, including the anatomical basis of the Rome diagnostic criteria, the potential confusion of symptom descriptors, and patients' biases towards higher symptom intensity ratings. Overlapping DGBI could also be caused by mechanistic factors such as pathophysiological mechanisms involving multiple gastrointestinal segments, and the effect of disorders in one segment on sensorimotor function in remote gastrointestinal parts, through neural or hormonal signalling. Key initial steps in the management of overlapping DGBI are detailed history taking, which can be facilitated using pictograms; carefully assessing the relative timing and cohesion of different symptoms; and recognising associated psychosocial dysfunction. Unnecessary technical investigations and complex combination treatment schedules should be avoided. Based on the identification of the dominant symptom pattern and putative underlying pathophysiological mechanisms, a single treatment modality should preferably be initiated, considering the efficacy spectrum of different therapies. Follow-up of the patient's condition allows the therapeutic approach to be adjusted as needed, while avoiding unnecessary additional technical investigations.

Indexed as

Brain-Gut AxisGastrointestinal DiseasesHumans

Identifiers

PMID36702144
PMCPMC7615746

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.